ASTEX PHARMACEUTICALS, INC Operating Income
ASTEX PHARMACEUTICALS, INC reported Operating Income of -$7.11 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2013-08-09
- ASTEX PHARMACEUTICALS, INC operating income (loss) for the quarter ending 2013-06-30 was -$7.11M.
- ASTEX PHARMACEUTICALS, INC operating income (loss) for the quarter ending 2013-03-31 was -$1.82M, a 224.38% decline year-over-year.
- ASTEX PHARMACEUTICALS, INC operating income (loss) for the quarter ending 2012-12-31 was $1.28M.
- ASTEX PHARMACEUTICALS, INC operating income (loss) for the quarter ending 2012-09-30 was -$9.39M.
- ASTEX PHARMACEUTICALS, INC operating income (loss) for fiscal 2012 was -$7.05M, a 392.37% decline from fiscal 2011.
- ASTEX PHARMACEUTICALS, INC operating income (loss) for fiscal 2011 was $2.41M, a 84.82% decline from fiscal 2010.
- ASTEX PHARMACEUTICALS, INC operating income (loss) for fiscal 2010 was $15.89M, a 401.93% increase from fiscal 2009.
- ASTEX PHARMACEUTICALS, INC operating income (loss) for fiscal 2009 was $3.17M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2013-06-30 | -$7.11M 10-Q · filed 2013-08-09 | -$8.93M 10-Q · filed 2013-08-09 | -$7.64M derived: sum of 3 quarters · filed 2013-08-09 | -$17.04M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | -$1.82M 10-Q · filed 2013-05-10 | -$532.00K derived: sum of 2 quarters · filed 2013-05-10 | -$9.92M derived: sum of 3 quarters · filed 2013-05-10 | -$10.33M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$8.11M derived: sum of 2 quarters · filed 2013-03-18 | -$8.51M derived: sum of 3 quarters · filed 2013-08-09 | -$7.05M 10-K · filed 2013-03-18 |
| 2012-09-30 | -$9.39M 10-Q · filed 2012-11-09 | -$9.80M derived: sum of 2 quarters · filed 2013-08-09 | -$8.34M 10-Q · filed 2012-11-09 | -$9.07M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | -$405.00K 10-Q · filed 2013-08-09 | $1.05M 10-Q · filed 2013-08-09 | $319.00K derived: sum of 3 quarters · filed 2013-08-09 | -$2.86M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | $1.46M 10-Q · filed 2013-05-10 | $724.00K derived: sum of 2 quarters · filed 2013-05-10 | -$2.46M derived: sum of 3 quarters · filed 2013-05-10 | -$1.61M derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | -$736.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$3.92M derived: sum of 2 quarters · filed 2013-03-18 | -$3.07M derived: sum of 3 quarters · filed 2013-03-18 | $2.41M 10-K · filed 2013-03-18 |
| 2011-09-30 | -$3.18M 10-Q · filed 2012-11-09 | -$2.34M derived: sum of 2 quarters · filed 2012-11-09 | $3.15M 10-Q · filed 2012-11-09 | $9.63M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $842.00K 10-Q · filed 2012-08-09 | $6.33M 10-Q · filed 2012-08-09 | $12.81M derived: sum of 3 quarters · filed 2013-03-18 | $16.67M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $5.49M 10-Q · filed 2012-05-10 | $11.97M derived: sum of 2 quarters · filed 2013-03-18 | $15.83M derived: sum of 3 quarters · filed 2013-03-18 | $16.75M derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | $6.49M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $10.35M derived: sum of 2 quarters · filed 2013-03-18 | $11.26M derived: sum of 3 quarters · filed 2013-03-18 | $15.89M 10-K · filed 2013-03-18 |
| 2010-09-30 | $3.86M 10-Q · filed 2011-11-09 | $4.78M derived: sum of 2 quarters · filed 2011-11-09 | $9.40M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $915.00K 10-Q · filed 2011-08-09 | $5.54M 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | $3.17M 10-K · filed 2012-03-15 |